BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12939413)

  • 41. Global DNA methylation and oxidative stress biomarkers in workers exposed to metal oxide nanoparticles.
    Liou SH; Wu WT; Liao HY; Chen CY; Tsai CY; Jung WT; Lee HL
    J Hazard Mater; 2017 Jun; 331():329-335. PubMed ID: 28273583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Production of 15-F
    Kuhn MJ; Mavangira V; Gandy JC; Sordillo LM
    J Dairy Sci; 2018 Oct; 101(10):9287-9295. PubMed ID: 30077444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.
    Reed TT; Pierce WM; Markesbery WR; Butterfield DA
    Brain Res; 2009 Jun; 1274():66-76. PubMed ID: 19374891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. F2-isoprostanes as markers of oxidant stress: an overview.
    Musiek ES; Morrow JD
    Curr Protoc Toxicol; 2005 Jun; Chapter 17():Unit 17.5. PubMed ID: 23045114
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease.
    Reich EE; Markesbery WR; Roberts LJ; Swift LL; Morrow JD; Montine TJ
    Am J Pathol; 2001 Jan; 158(1):293-7. PubMed ID: 11141503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potential applications of lipid peroxidation products - F
    De Las Heras-Gómez I; Medina S; Casas-Pina T; Marín-Soler L; Tomás A; Martínez-Hernández P; Oger C; Galano JM; Durand T; Jimeno L; Llorente S; Lozoya E; Ferreres F; Gil-Izquierdo Á
    Free Radic Biol Med; 2017 Mar; 104():178-184. PubMed ID: 28089724
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases.
    Montine KS; Quinn JF; Zhang J; Fessel JP; Roberts LJ; Morrow JD; Montine TJ
    Chem Phys Lipids; 2004 Mar; 128(1-2):117-24. PubMed ID: 15037157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Oxidative stress marker].
    Katayama S
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():142-6. PubMed ID: 16981533
    [No Abstract]   [Full Text] [Related]  

  • 49. Development of enzyme-linked immunosorbent assay for 8-iso-prostaglandin F2alpha, a biomarker of oxidative stress in vivo, and its application to the quantification in aged rats.
    Chu X; Ageishi Y; Nishimura K; Jisaka M; Nagaya T; Shono F; Yokota K
    J Pharm Biomed Anal; 2009 Dec; 50(5):911-6. PubMed ID: 19581065
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential oxidative stress biomarkers of mild cognitive impairment due to Alzheimer disease.
    García-Blanco A; Baquero M; Vento M; Gil E; Bataller L; Cháfer-Pericás C
    J Neurol Sci; 2017 Feb; 373():295-302. PubMed ID: 28131209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias.
    Casado A; Encarnación López-Fernández M; Concepción Casado M; de La Torre R
    Neurochem Res; 2008 Mar; 33(3):450-8. PubMed ID: 17721818
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward?
    Halliwell B
    Cardiovasc Res; 2000 Aug; 47(3):410-8. PubMed ID: 10963714
    [No Abstract]   [Full Text] [Related]  

  • 53. [Isoprostanes, a new substance group in angiology--of future significance?].
    Aghajanian AA; Oguogho A; Sinzinger H
    Vasa; 1997 May; 26(2):65-9. PubMed ID: 9221617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease.
    Marcus DL; Thomas C; Rodriguez C; Simberkoff K; Tsai JS; Strafaci JA; Freedman ML
    Exp Neurol; 1998 Mar; 150(1):40-4. PubMed ID: 9514828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Markers of lipid oxidative damage in the exhaled breath condensate of nano TiO
    Pelclova D; Zdimal V; Kacer P; Zikova N; Komarc M; Fenclova Z; Vlckova S; Schwarz J; Makeš O; Syslova K; Navratil T; Turci F; Corazzari I; Zakharov S; Bello D
    Nanotoxicology; 2017 Feb; 11(1):52-63. PubMed ID: 27855548
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Measurement of plasma antioxidant reserve after supplementation with various antioxidants in healthy subjects.
    Rabovsky A; Cuomo J; Eich N
    Clin Chim Acta; 2006 Sep; 371(1-2):55-60. PubMed ID: 16603143
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitation of plasma total 15-series F(2)-isoprostanes by sequential solid phase and liquid-liquid extraction.
    Taylor AW; Traber MG
    Anal Biochem; 2010 Jan; 396(2):319-21. PubMed ID: 19788885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics.
    Sultana R; Perluigi M; Butterfield DA
    Antioxid Redox Signal; 2006; 8(11-12):2021-37. PubMed ID: 17034347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between levels of oxidative DNA damage, lipid peroxidation and mitochondrial membrane potential in young and old F344 rats.
    Wong YT; Ruan R; Tay FE
    Free Radic Res; 2006 Apr; 40(4):393-402. PubMed ID: 16517504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis.
    Montuschi P; Kharitonov SA; Ciabattoni G; Corradi M; van Rensen L; Geddes DM; Hodson ME; Barnes PJ
    Thorax; 2000 Mar; 55(3):205-9. PubMed ID: 10679539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.